Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results
AUSTIN, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced financial and business results […]
CDW Corporation Announces Proposed Registered Offering of $630 Million of Senior Notes due 2029
LINCOLNSHIRE, Ill., Aug. 10, 2020 (GLOBE NEWSWIRE) — CDW Corporation (NASDAQ: CDW), a leading multi-brand technology solutions provider to business, […]
Paratek Pharmaceuticals Announces Second Quarter 2020 Total Revenue of $9.3 Million including NUZYRA® (omadacycline) Net Revenue of $8.1 Million
— Paratek Raises Full Year 2020 Revenue Guidance; Total Revenue guidance expected to be Between $78 and $83 Million Driven by Strong NUZYRA Net Revenue— [...]
Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress
Interim RMC-4630 Data Support Benefit of Intermittent Dosing and Corroborate Clinical Activity Against Genetically-Defined TumorsTargeted Combination Strategy Underpins Initiation of […]
Intra-Cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate Update
NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development […]
Aemetis to Review Second Quarter Financial Results on August 13, 2020
CUPERTINO, CA, Aug. 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will […]
Ocugen Receives Fourth FDA Orphan Drug Designation for the Same Product, OCU400 (AAV-NR2E3) Gene Therapy, for the Treatment of Another Key Inherited Retinal Disease (IRD), PDE6B Gene Mutation-Associated Retinal Diseases
MALVERN, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and […]
Aquestive Therapeutics Receives FDA Fast Track Designation for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Treatment of Allergic Reactions Including Anaphylaxis
Finalizing preparations for pharmacokinetic (PK) clinical trials of AQST-108First planned PK clinical trial expected to begin during the third quarter […]
Serengeti Provides Kwanika Update – Drilling to Begin
VANCOUVER, British Columbia, Aug. 10, 2020 (GLOBE NEWSWIRE) — Serengeti Resources Inc. (SIR: TSX-V) (“Serengeti” or “the Company”) is pleased to […]
FTI Consulting Leads Who’s Who Legal Restructuring & Insolvency Advisers List
WASHINGTON, Aug. 10, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that 26 professionals from the firm’s […]
